Nuvalent (NUVL) Assets Average (2021 - 2026)
Nuvalent (NUVL) reported Assets Average of $1.4 billion for Q1 2026, up 22.08% on a YoY basis from $1.1 billion in Q1 2025, and up 14.68% quarter-over-quarter from $1.2 billion in Q4 2025.
Nuvalent (NUVL) Assets Average (2021 - 2026) Analysis & Trends
Nuvalent has reported Assets Average for 6 years, with the latest figure at $1.4 billion in Q1 2026.
- For the quarter ending Q1 2026, Assets Average rose 22.08% year-over-year to $1.4 billion; the trailing twelve-month figure through Mar 2026 stood at $1.4 billion (up 22.08% YoY), and the FY2025 full-year result was $1.3 billion, up 36.3% from the prior year.
- Assets Average for Q1 2026 stood at $1.4 billion, up from $1.2 billion in the prior quarter.
- The five-year high for Assets Average was $1.4 billion in Q1 2026, with the low at $256.3 million in Q3 2022.
- Historically, Assets Average has averaged $729.3 million across 5 years, with a median of $691.8 million in 2024.
- Annual changes were most pronounced in 2024 — Assets Average surged 115.0% — and 2025, when it rose 2.66%.
- Nuvalent's Assets Average stood at $366.0 million in 2022, then surged by 58.12% to $578.7 million in 2023, then soared by 101.35% to $1.2 billion in 2024, then grew by 2.66% to $1.2 billion in 2025, then advanced by 14.68% to $1.4 billion in 2026.
- The last three Assets Average figures came in at $1.4 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.0 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 40.89 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 26.03 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 660.38 Mn |
| 10 | Nuvalent | 9.70 Bn | 9.70 Bn | - | 1.37 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.37 Bn |
| Dec 31, 2025 | 1.20 Bn |
| Sep 30, 2025 | 1.01 Bn |
| Jun 30, 2025 | 1.07 Bn |
| Mar 31, 2025 | 1.12 Bn |
| Dec 31, 2024 | 1.17 Bn |
| Sep 30, 2024 | 932.04 Mn |
| Jun 30, 2024 | 691.85 Mn |
| Mar 31, 2024 | 720.43 Mn |
| Dec 31, 2023 | 578.73 Mn |
| Sep 30, 2023 | 433.51 Mn |
| Jun 30, 2023 | 451.47 Mn |
| Mar 31, 2023 | 471.72 Mn |
| Dec 31, 2022 | 366.01 Mn |
| Sep 30, 2022 | 256.29 Mn |
| Jun 30, 2022 | 270.03 Mn |
| Mar 31, 2022 | 285.43 Mn |
| Dec 31, 2021 | 300.90 Mn |
| Sep 30, 2021 | 225.74 Mn |